Provectus Biopharmaceuticals (PVCT) Return on Assets [ROA] (2011 - 2026)
Provectus Biopharmaceuticals' Return on Assets [ROA] was -491.22% in Q2 2026, up 434.13 percentage points from -925.36% a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Provectus Biopharmaceuticals came in at -646.23%, down 258.29 percentage points from FY2024.
- Return on Assets [ROA] has now declined for three consecutive years, though with a five-year change of +3.13 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -387.94% in FY2024 (-209.99 pp), -177.95% in FY2023 (-54.43 pp), -123.52% in FY2022 (+151.14 pp) and -274.66% in FY2021 (+374.71 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q3 2024.
- Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last seven quarters, with an average year-over-year change of -351.28 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2022 (a gain of 960.41 percentage points); the worst was Q3 2025 (a drop of 820.92 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.26 Bn | 1,101.85 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.92 Bn | 555.78 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 506.32 Bn | 479.44 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.38 Bn | 312.76 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 293.00 Bn | 256.99 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.76 Bn | 239.44 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.88 Bn | 193.27 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.26 Bn | 169.45 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.34 Bn | 117.99 Bn | 10.94 Bn | 2.14% |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | -491.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -491.22% |
| Dec 31, 2025 | -985.34% |
| Sep 30, 2025 | -1,179.07% |
| Jun 30, 2025 | -925.36% |
| Mar 31, 2025 | -648.09% |
| Dec 31, 2024 | -526.70% |
| Sep 30, 2024 | -358.15% |
| Jun 30, 2024 | -275.88% |
| Mar 31, 2024 | -207.54% |
| Dec 31, 2023 | -184.86% |
| Sep 30, 2023 | -176.52% |
| Jun 30, 2023 | -172.14% |
| Mar 31, 2023 | -170.86% |
| Dec 31, 2022 | -167.72% |
| Sep 30, 2022 | -177.25% |
| Jun 30, 2022 | -168.00% |
| Mar 31, 2022 | -158.37% |
| Dec 31, 2021 | -273.91% |
| Sep 30, 2021 | -1,137.66% |
| Jun 30, 2021 | -1,063.41% |
API Access
Provectus Biopharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();